<?xml version="1.0" encoding="UTF-8"?>
<ref id="cit0015">
 <label>15.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Walmsley</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Bernstein</surname>
    <given-names>B</given-names>
   </name>, 
   <name name-style="western">
    <surname>King</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Arribas</surname>
    <given-names>J</given-names>
   </name>, 
   <name name-style="western">
    <surname>Beall</surname>
    <given-names>G</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ruane</surname>
    <given-names>P</given-names>
   </name>, 
   <name name-style="western">
    <surname>Brun</surname>
    <given-names>S</given-names>
   </name>
  </person-group>
  <article-title>Lopinavir–ritonavir versus nelfinavir for the initial treatment of HIV infection</article-title>. 
  <source>New Engl J Med</source>. 
  <year>2002</year>;
  <volume>346</volume>(
  <issue>26</issue>):
  <fpage>2039</fpage>–
  <lpage>46</lpage>. doi:
  <pub-id pub-id-type="doi">10.1056/NEJMoa012354</pub-id>.
  <pub-id pub-id-type="pmid">12087139</pub-id>
 </mixed-citation>
</ref>
